Skip to Content

CXI Healthcare Technology Group Ltd 900120

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

900120 is trading at a 42% discount.
Price
KRW 109.29
Fair Value
KRW 723.44
Uncertainty
Extreme
1-Star Price
KRW 537.73
5-Star Price
KRW 65.93
Economic Moat
Pxvp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 900120 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
$107.00110.00
52-Week Range
Bid/Ask
$109.00 / $109.00
Market Cap
$31.13 Bil
Volume/Avg
1.1 Mil / 3.8 Mil

Key Statistics

Price/Earnings (Normalized)
1.08
Price/Sales
0.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CXI Healthcare Technology Group Ltd is a food manufacturing and distribution company. It operates through subsidiaries that manufacture nutritional supplements. The company's products include Traditional Chinese medicines in the form of a capsule, drinks, and tea. All of its products are marketed only in China.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
11

Valuation

Metric
900120
Price/Earnings (Normalized)
1.08
Price/Book Value
0.07
Price/Sales
0.36
Price/Cash Flow
0.61
Price/Earnings
900120

Financial Strength

Metric
900120
Quick Ratio
77.16
Current Ratio
77.86
Interest Coverage
3,272.70
Quick Ratio
900120

Profitability

Metric
900120
Return on Assets (Normalized)
4.26%
Return on Equity (Normalized)
4.37%
Return on Invested Capital (Normalized)
4.23%
Return on Assets
900120
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHwttbygxLcjj$72.4 Bil
MKKGY
Merck KGaA ADRMfshsjgdtPsrgms$70.8 Bil
HLN
Haleon PLC ADRZkcdmhydHsd$37.7 Bil
VTRS
Viatris IncXmdfvygnqVwxs$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNvjvwgtwbWszy$12.5 Bil
CTLT
Catalent IncFgkhdwrRxtdg$10.1 Bil
PRGO
Perrigo Co PLCFgnqjsycYwg$4.3 Bil
CURLF
Curaleaf Holdings IncGxbzmryfxMwrrv$3.7 Bil
PBH
Prestige Consumer Healthcare IncBsnlgykcNwnzwf$3.5 Bil
GTBIF
Green Thumb Industries IncVpxklsnzqqCvkq$2.9 Bil

Sponsor Center